TY - JOUR
T1 - Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis involvement of Giα2-linked Rho kinase activity
AU - Liu, F.
AU - Verin, A. D.
AU - Wang, P.
AU - Day, R.
AU - Wersto, R. P.
AU - Chrest, F. J.
AU - English, D. K.
AU - Garcia, J. G.N.
PY - 2001
Y1 - 2001
N2 - We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.
AB - We compared stimulus-coupling pathways involved in bovine pulmonary artery (PA) and lung microvascular endothelial cell migration evoked by sphingosine-1-phosphate (S1P), a potent bioactive lipid released from activated platelets, and by vascular endothelial growth factor (VEGF), a well-recognized angiogenic factor. S1P-induced endothelial cell migration was maximum at 1 μM (∼ 8-fold increase with PA endothelium) and surpassed the maximal response evoked by either VEGF (10 ng/ml) (∼ 2.5-fold increase) or hepatocyte growth factor (HGF) (∼ 2.5-fold increase). Migration induced by S1P, but not by VEGF, was significantly inhibited by treatment with antisense oligonucleotides directed to Edg-1 and Edg-3 (endothelial differentiation gene) S1P receptors and by G protein modification. These strategies included pretreatment with pertussis toxin, or transfection with mini-genes encoding a βγ subunit inhibitory peptide of the β-adrenergic receptor kinase, or an 11-amino-acid peptide that inhibits G1α2 signaling. Various strategies to interrupt Rho family signaling, including C3 exotoxin, dominant/negative Rho, or the addition of Y27632, a cell-permeable Rho kinase inhibitor, significantly attenuated S1P- but not VEGF-induced migration. Conversely, pharmacologic inhibition of either myosin light chain kinase, src family tyrosine kinases, or phosphatidylinositol-3′ kinase reduced basal endothelial cell migration and abolished VEGF-induced endothelial cell migration but did not inhibit the increase in S1P-induced migration. Whereas VEGF and S1P increased both p42/p44 extracellular regulated kinase and p38 mitogen-activated protein (MAP) kinase activities, only p38 MAP kinase inhibition significantly reduced VEGF- and S1P-stimulated migration. These data confirm S1P as a potent endothelial cell chemoattractant through G1α2-coupled Edg receptors linked to Rho-associated kinase and p38 MAP kinase activation. The divergence in signaling pathways evoked by S1P and VEGF suggests complex and agonist-specific regulation of endothelial cell angiogenic responses.
UR - http://www.scopus.com/inward/record.url?scp=0034974903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034974903&partnerID=8YFLogxK
U2 - 10.1165/ajrcmb.24.6.4323
DO - 10.1165/ajrcmb.24.6.4323
M3 - Article
C2 - 11415936
AN - SCOPUS:0034974903
SN - 1044-1549
VL - 24
SP - 711
EP - 719
JO - American Journal of Respiratory Cell and Molecular Biology
JF - American Journal of Respiratory Cell and Molecular Biology
IS - 6
ER -